medigraphic.com
ISSN 1684-1824 (Electronic)

2016, Number 3

<< Back Next >>

Rev Méd Electrón 2016; 38 (3)

Application of Borga’s fatigue index in patients with Chronic Obstructive Pulmonary Disease (COPD)

Martínez HA, Garcia SE, Tamargo BTO, Sardiñas GO, García HM

Language: Spanish
References: 18
Page: 394-401
PDF size: 63.08 Kb.


ABSTRACT

Background: it is recognized that COPD is a multidimensional disease affecting several organs; when they fail, they cause hypoxia and fatigue. A subjective indicator for detecting fatigue is Borga’s fatigue index.
Aim: Identify the behaviour of the index of fatigue of Borg.
Materials and Methods: a prospective, observational study, of correlational research was carried out in a group of patients with confirmed diagnostic of obstructive pulmonary disease, to whom the PM6M was applied, including the Borga’s fatigue index before and after the walk of that trial.
Outcomes: the average of the basal Borga’s fatigue index was 0.94 and of 1.75 at the end, with a difference between them of 0.81. The correlation between the final index and oxygen saturation was 0 (p=0,989), and between the final Borga’s fatigue index and the walked distance was -0,36 (p=0,002).
Conclusions: the average of the final Borga’s fatigue index was higher than the basal one, with a significant difference between both media. The correlation between the final Borga’s fatigue index and the oxygen saturation was null. The walked distance and the final Borga’s fatigue index showed a proportionally inverse correlation.


REFERENCES

  1. GesEPOC. Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC) - Guía Española de la EPOC (GesEPOC).Arch Bronconeumol [Internet]. Jun 2012 [citado 3 May 2014];48(Supl 1). Disponible en: http://www.archbronconeumol.org/index.php?p=watermark&idApp=UINPBA00003Z &piiItem=S0300289612700352&origen=bronco&web=bronco&urlApp=http://www. archbronconeumol.org&estadoItem=S300&idiomaItem=es

  2. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65. Citado en PubMed; PMID: 22878278.

  3. Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Exp Rev Respir Med. 2011;5(5):647–62. Citado en PubMed; PMID: 21955235.

  4. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence- based guidelines. Chest. 2007 May;131(5 Suppl):4S-42S. Citado en PubMed; PMID: 17494825.

  5. Levine S, Kaiser L, Leferovich J, et al. Cellular adaptions in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med [Internet].1997[citado 18 Mar 2011];337:1799-1806.Disponible en: http://www.nejm.org/doi/full/10.1056/NEJM199712183372503

  6. Ortega F. Respuesta al ejercicio. En: Martín P, Ramos G, Sanchis J, eds. Medicina Respiratoria. 2ª ed. Madrid: Grupo Aula Médica; 2006.61-71 p.

  7. Morales Moya JM. La percepción subjetiva del esfuerzo como parte de la evaluación de la intensidad del entrenamiento. Rev Digital Buenos Aires [Internet]. 2004[citado 18 Mar 2011];(73). Disponible en: http://www.efdeportes.com.

  8. Saey D, Côté CH, Mador MJ, et al. Assessment of muscle fatigue during exercise in chronic obstructive pulmonary disease. Muscle Nerve. 2006:34(1):62–71. Citado en PubMed; PMID: 16583366.

  9. Van Remoortel H, Hornikx M, Demeyer H, et al. Daily physical activity in subjects with newly diagnosed COPD. Thorax. 2013;68(10):962–3. Citado en PubMed; PMID: 23604460.

  10. O’Donnell DE, Guenette JA, Maltais F, et al. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest. 2012;141(3):753–62. Citado en PubMed; PMID: 21852298.

  11. Spruit MA, Watkins ML, Edwards LD, et al. Determinants of poor 6–min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med. 2010;104(6):849– 57. Citado en PubMed; PMID: 20471236.

  12. Agustín AGN, Sauleda J, Morlá M, et al. Disfunción muscular esquelética de la EPOC. Mecanismos celulares.Arch Bronconeumol. 2001;37(4):197-205. Citado en PubMed; PMID: 11412505.

  13. Barreiro E, Ferrer D, Sanchez F, et al. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol. septiembre 2011;111(3):808-17. Citado en PubMed; PMID: 21636562.

  14. Romme EA, Smeenk FW, Rutten EP, et al. Osteoporosis in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2013;7(4):397–410. Citado en PubMed; PMID: 23952337.

  15. John M, Hoernig S, Doehner W, et al. Anemia and inflammation in COPD. Chest 2005;127(3): 825-9.Citado en PubMed; PMID: 15764763.

  16. Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta–analysis. Am J Clin Nutr. 2012;95(6):1385–95. Citado en PubMed; PMID: 22513295.

  17. Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta–analysis. Respirology. 2013;18(4):616–29. Citado en PubMed; PMID: 23432923.

  18. Burgel PR, Escamilla R, Perez T, et al. Impact of comorbidities on COPD–specific health–related quality of life. Respir Med. 2013;107(2):233–41. Citado en PubMed; PMID: 23098687.




2020     |     www.medigraphic.com